Intracellular and extracellular labile iron pools

Advances in Experimental Medicine and Biology

Volumn 509, Issue , 2003, Pages 55-75

  Cabantchik, Z Ioav ^a   Kakhlon, Or ^a   Epsztejn, Silvina ^b   Zanninelli, Giulianna ^a   Breuer, William ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON; IRON CHELATE; SIDEROPHORE; TRANSFERRIN; APOPROTEIN; APOTRANSFERRIN; FERRITIN; FLUORESCENT DYE; IRON CHELATING AGENT;

BINDING AFFINITY; BIOACCUMULATION; BIOSENSOR; CELL LEVEL; CHEMICAL STRUCTURE; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; FLUORESCENCE; HUMAN; INTRACELLULAR SPACE; IRON CHELATION; IRON OVERLOAD; IRON STORAGE; LIVER LEVEL; METAL BINDING; NONHUMAN; OXIDATION REDUCTION REACTION; PARAMETER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; STEADY STATE; TECHNIQUE; THEORETICAL MODEL; ANIMAL; BLOOD; CELL LINE; INTRACELLULAR FLUID; KINETICS; METABOLISM;

ANIMALS; APOPROTEINS; CELL LINE; DEFEROXAMINE; EXTRACELLULAR SPACE; FERRITINS; FLUORESCENT DYES; HUMANS; INTRACELLULAR FLUID; IRON; IRON CHELATING AGENTS; KINETICS; PROTEIN BINDING; TRANSFERRIN;

EID: 0041308118     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (70)

1. Crichton, R.R. (1991). Inorganic Biochemistry of Iron Metabolism. New York, London, Toronto, Sydney, Tokyo, Singapore, Ellis Horwood
2. Epsztejn, S., Kakhlon, O., Breuer, W. Glickstein, H. and Cabantchik, Z.I. (1997) A fluorescence assay for the labile iron pool (LIP) of mammalian cells. Anal. Biochem. 248:31-40
3. Breuer, V.W., Epstejn, S., Milgram, P. and Cabantchik, Z.I. (1995). Transport of iron and other related metals into cells as revealed by a fluorescent probe. Am. J. Physiol. (Cell) 268:1354-1361
4. Breuer, W., Epstejn, S., and Cabantchik, Z.I. (1995). Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270:24209-24215
5. Jacobs, A. (1977) An intracellular transit iron pool. Blood. 50:4331-4336
6. Kozlov, A.V., Yegorov, D.Y., Vladimirov, Y.A. and Azizova, O.A. (1992). Intracellular iron in liver tissue and liver homegenate-studies with electron paramagnetic resonance on the formation of paramagnetic complexes with desferal and nitric oxide. Free Rad. Biol. Med. 13:9-16
7. Rothman, R.J., Serroni, A. and Farber, J.L. (1992). Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from Ft, that is involved in oxidative cell injury. Mol. Pharmacol. 42:703-710
8. Eisenstein, R.D. (2000) Iron regulator proteins and the molecular control of mammalian iron metabolism Annu. Rev. Nutr. 20:627-62
9. Aisen P, Wessling-Resnick M, Leibold EA. Iron metabolism (1999). Curr Opin Chem Biol 3:200-6
10. Hershko H, Graham G, Bates GW, Rachmilewitz E: Nonspecific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Brit. J. Haematol. 1978; 40:233-263.
11. Graham G, Bates GW, Rachmilewitz EA, Hershko C: Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am. J. Hematol. 1979; 6:207-217.
12. Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S: Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood. 1996; 88:703-13.
13. Batey RG, Lai Chung Fong P, Shamir S, Sherlock S: A non-transferrin- bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 1980; 25:340-6.
14. Aruoma OI, Bomford A, Polson RJ, Halliwell B: Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood. 1988; 72:1416-9.
15. Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC: Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J. Hepatol. 2000; 32:727-33.
16. Breuer W, Hershko C, Cabantchik ZI. (2000) The importance of non-transferrin iron in disorders of iron metabolism. Transfusion Sci. 2000; 23:183-92.
17. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC: Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal. Biochem. 1999; 273:212-20.
18. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI: The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood. 2000; 95:2975-82.
19. Breuer W, Ermers, MJJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI: Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin bound iron (NTBI) used for assessing chelation therapy. Blood. 97:792-1.
20. Halliwell B, Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990; 186:1-83.
21. Wright TL, Brissot P, Ma WL, Weisiger RA: Characterization of non-transferrin-bound iron clearance by rat liver. J Biol Chem. 1986; 261:10909-14.
22. Kaplan J, Jordan I, Sturrock A: Regulation of the transferrin- independent iron transport system in cultured cells. J Biol. Chem. 1991; 266:2997-3004.
23. Shalev O, Repka T, Goldfarb A, Grinberg L, Abrahamov A, Olivieri NF, Rachmilewitz EA, Hebbel RP. 1995. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood. 86:2008-13.
24. Cabantchik ZI, Breuer W, Slotki I, Beaumont C. (2001) Development and application of novel fluorescent assays for probing labile iron pools in biological systems. In: Badman DG, Bergeron RJ, Brittenham GM, eds. Iron Chelators: New development strategies. Ponte Vedra, FL: The Saratoga Group; 2000:353-383.
25. Tsien, R.Y. (1989) Fluorescent probes of cell signaling. Ann. Rev. Neurosci. 12:227-33
26. Ramachandram, B. and A. Samanta, A. 1998. How important is the quenching influence of the transition metal ions in the design of fluorescent PET sensors? Chemical Physics Letters 290:9-16
27. Lytton, S.J., Mester, B., Libman, J., Shanzer, A. and Cabantchik, Z.I. (1992). Monitoring of iron(III) removal from biological sources using a novel fluorescent siderophore. Anal. Biochem. 205:326-333
28. Werta, M.H.V., Hofstraát, J.W., Geurts, F.A.J., and Verhoeven, J.W. 1997 Fluorescein and eosin as sensitizing chromophores in near-infrared luminescent ytterbium(III), neodymium(III) and Terbium(III) chelates. Chemical Physics Letters 276:196-201
29. Breuer W and Cabantchik ZI. (2001) A fluorescence-based one-step assay for serum non-transferrin bound iron (NTBI). Anal. Biochem. (submitted).
30. Ramachandram, B. and A. Samanta, A. 1998. Transition Metal Ion Induced Fluorescence Enhancement of 4-(N, N-Dimethylethylenediamino)-7-nitrobenz-2-oxa- 1,3-diazole. J. Phys. Chem. 102:10379-10387.
31. Petrat F, Rauen U, de Groot H. 1999. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology. 29:1171-9.
32. Thomas F, Serratrice G, Beguin C, Aman ES, Pierre JL, Fontecave M, Laulhere JP. 1999 Calcein as a fluorescent probe for ferric iron. Application to iron nutrition in plant cells. J. Biol. Chem. 274:13373-83
33. Staubli A, Boelsterli UA 1998. The labile iron pool in hepatocytes: prooxidant-induced increase in free iron precedes oxidative cell injury. Am. J. Physiol. 274:G1031-7.
34. Epsztejn, S., Picard, V., Breuer, W.V., Glickstein, H., Slotki, I.N., Beaumont C. and Cabantchik, Z.I. (1999). Functional consequences of H-ferritin over-expression in transfected cells. Blood. 94:3593-3603.
35. Richardson, D.R. and Ponka, P. 1997 The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta. 1331:1-40
36. Cabantchik, Z.I., Milgram, P., Glickstein, H. and Breuer, W., (1993) A method for assessing iron chelation in membrane model systems and in living mammalian cells. Anal. Biochem. 233:221-227.
37. Zanninelli, G., Brissot, P., Hider, R.R., Konijn, A.P., Shanzer, A. and Cabantchik, Z.I. (1997). Chelation and mobilization of cellular iron by different classes of iron chelators. Mol. Pharmacol. 51:842-852.
38. Bevilacqua, M.A., Faniello, M.C., Quaresima, B., Tiano, M.T., Giuliano, P., Feliciello, A., Avvedimento, V.E., Cimino, F. & Costanzo, F. (1997) A common mechanism underlying the E1A repression and the cAMP stimulation of the H ferritin transcription. J. Biol. Chem. 272:20736-20741
39. Bevilacqua, M.A., Faniello, M.C., Russo, T., Cimino, F. & Costanzo, F. (1998) P/CAF/p300 complex binds the promoter for the heavy subunit of ferritin and contributes to its tissue-specific expression. Biochem. J. 335:521-523
40. Fuhrmann, G., Rosenberger, G., Grusch, M., Klein, N., Hofmann, J. & Krupitza, G. (1999) The MYC dualism in growth and death. Mutat. Res. 437:205-217
41. Tsuji, Y., Kwak, E., Saika, T., Torti, S.V. & Torti, F.M. (1993) Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J. Biol. Chem. 268:7270-7275
42. Tsuji, Y., Akebi, N., Lam, T.K., Nakabeppu, Y., Torti, S.V. & Torti, F.M. (1995) FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol. Cell Biol. 15:5152-5164
43. Tsuji, Y., Moran, E., Torti, S.V. & Torti, F.M. (1999) Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/ CBP adaptor proteins in FER-1 enhancer activity. J. Biol. Chem. 274:7501-7507
44. Wu, K.J., Polack, A. & Dalla Favera, R. (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676-679
45. Pinero, D.J., Hu, J., Cook, B.M., Scaduto, R.C. & Connor, J.R. (2000) Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim. Biophys. Acta. 1497:279-288
46. Picard, V., Renaudie, F., Porcher, C., Hentze, M.W., Grandchamp, B. & Beaumont, C. (1996) Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution. Blood. 87:2057-2064
47. Picard, V., Epsztejn, S., Santambrogio, P., Cabantchik, Z.I. & Beaumont, C. (1998) Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J. Biol. Chem. 273:15382-15386
48. Cozzi, A., Corsi, B., Levi S., Santambrogio, P., Albertini, A. & Arosio, P. (2000) Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J. Biol. Chem. 275:25122-25129
49. Kakhlon, A., Gruenbaum, Y. & Cabantchik, Z.I. (2001) Repression of ferritin expression increases the labile iron pool, oxidative stress, and short term growth of human erythroleukemia cells. Blood. 97:2863-2871.
50. Kakhlon O, Gruenbaum Y, Cabantchik Z.I. (2001) Repression of the heavy ferritin chain increases the labile iron pool of human K562 cells. Biochem. J. 2001 Jun 1;336 (Pt 2):311-316.
51. Tilbrook, G.S. and Hider, R.C. Iron chelators for clinical use. In: Sigel, A. and Sigel, H., eds. Metal Ions in Biological Systems: Iron Transport and Storage in Microorganisms, Plants and Animals. 1998;Vol. 35:691-730. Marcel Dekker, New York.
52. Pollack S, Aisen P, Lasky FD, Vanderhoff G. (1976) Chelate mediated transfer of iron from transferrin to desferrioxamine. Br. J. Haematol. 34:231-5.
53. Pollack, S., Vanderhoff, G. and Lasky, F. (1977) Iron removal from transferrin - an experimental study. Biochim. Biophys. Acta. 497:481-487.
54. Kontoghiorghes, G.J. (1993) New concepts of iron and aluminium chelation therapy with oral L1 (Deferiprone) and other chelators. Analyst, 120:845-851.
55. Aisen P, Leibman A, Zweier J. (1978) Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem. 253:1930-7.
56. Evans, R.W., Sharma, M., Ogwang, W., Patel, K.J., Bartlett, A.N. and Kontoghiorghes. (1992) The effect of alpha-ketohydropyridine chelators on transferrin saturation in vitro and in vivo. Drugs of Today, 28 (Suppl. A):19-23.
57. Wang W.C., Ahmed N., Hanna M. (1986) J. Pediatr, 108:552-7 Non-transferrin-bound iron in long-term transfusion in children with congenital anemias.
58. Ahmed N.K., Hanna M., Wang W. (1986) Nontransferrin-bound serum iron in thalassemia and sickle cell patients. Intern. J. Biochem. 18:953-956.
59. Araujo A, Kosaryan M, MacDowell A, Wickens D, Puri S, Wonke B, Hoffbrand A.V. (1996) A novel delivery system for continuous desferrioxamine infusion in transfusional iron overload. Br. J. Haematol. 93:835-7.
60. al-Refaie FN., Wickens, DG., Wonke B. Kontoghiorghes GJ. and Hoffbrand AV. (1992). Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. Brit. J. Haematol. 82:431-436.
61. Wonke, B., Wright, C. and Hoffbrand, A.V. (1998) Combined therapy with deferiprone and desferrioxamine. Br. J. Haematol., 103:361-4.
62. th International Conferenoe on Oral Chelators, Limassol, Cyprus, Mar.22-26,2000.
63. Grady, R.W. and Giardina, P.J. Iron Chelation: Rationale for combination therapy. In: Badman, D.G., Bergeron, R.J. and Brittenham, G.M. eds. Iron Chelators: New development strategies. 2000; 293-310. The Saratoga Group, Ponte Vedra, FL.
64. Singh, S., Hider, R.C. and Porter, J.B. (1990) A direct method for quantification of non-transferrin-bound iron. Anal. Biochem. 186:320-323.
65. Evans, PJ, Halliwell, B. (1994). Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays. Meth. Enzymol. 233:82-89.
66. Scheiber B, Goldenberg H. (1998). The surface of rat hepatocytes can transfer iron from stable chelates to external acceptors. Hepatology. 27:1075-80.
67. Iancu TC, Deugnier Y, Halliday JW, Powell LW, Brissot P. (1997). Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J. Hepatol. 27:628-38.
68. Simpson RJ, Deenmamode J, McKie AT, Raja KB, Salisbary JR, Iancu TC, Peters TJ. (1997): Time-course of iron overload and biochemical, histopathological and ultrastructural evidence of pancreatic damage in hypotransferrinaemic mice. Clin. Sci. (Colch). 93:453-62.
69. Moura E, Noordormeer MA, Verhoeven N, Verheul AF, Marx JJ. (1998). Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood. 92:2511-9.
70. Grootveld, M., Bell, J.D., Halliwell, B., Aruoma, O.I., Bomford, A. and Sadler, P.J. (1989) Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis. J. Biol. Chem. 264:4417-22.